Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 6/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL829055 | 0.88 | ALDH1A1 (0.40) | LPAR1LPAR3ALDH1A1LMNA | |
| SCHEMBL12628934 | 0.87 | ALDH1A1 (0.45) | LPAR1LPAR3ALDH1A1LMNA | |
| SCHEMBL15686246 | 0.86 | TLR2 (0.34) | TLR2LPAR1LPAR3 | |
| SCHEMBL828854 | 0.82 | TLR2 (0.41) | TLR2LPAR1LPAR3ALDH1A1LMNA | |
| SCHEMBL14499216 | 0.80 | THRB (0.34) | — | |
| SCHEMBL10196074 | 0.79 | LPAR1 (0.32) | TLR2LPAR1LPAR3 | |
| SCHEMBL24470513 | 0.76 | LPAR1 (0.47) | TLR2LPAR1LPAR3 | |
| SCHEMBL10181716 | 0.76 | LPAR1 (0.47) | TLR2LPAR1LPAR3 | |
| SCHEMBL13032606 | 0.76 | LPAR1 (0.47) | TLR2LPAR1LPAR3 | |
| SCHEMBL25078771 | 0.76 | LPAR1 (0.47) | TLR2LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170240590-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-08-24 | — | — | US | disclosed |
| US-20170157259-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER INTERNATIONAL INC. | 2017-06-08 | — | — | US | disclosed |
| US-20160361430-A1 | BLOOD COAGULATION PROTEIN CONJUGATES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-12-15 | — | — | US | disclosed |
| US-9492555-B2 | Nucleophilic catalysts for oxime linkage | BAXALTA INCORPORATED (US) | 2016-11-15 | — | — | US | disclosed |
| US-20160120994-A1 | BLOOD COAGULATION PROTEIN CONJUGATES | BAXALTA INC (US) | 2016-05-05 | — | — | US | disclosed |
| US-20160058842-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER INTERNATIONAL INC. | 2016-03-03 | — | — | US | disclosed |
| US-8809501-B2 | Nucleophilic catalysts for oxime linkage | BAXTER INTERNATIONAL INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-20140121351-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | BAXTER HEALTHCARE SA (CH) | 2014-05-01 | — | — | US | disclosed |
| US-8642737-B2 | Nucleophilic catalysts for oxime linkage | BAXTER INTERNATIONAL INC. (US) | 2014-02-04 | — | — | US | disclosed |
| US-20140024808-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER HEALTHCARE SA (CH) | 2014-01-23 | — | — | US | disclosed |
| US-8071728-B2 | Factor VIII polymer conjugates | BAXTER INTERNATIONAL INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-8071725-B2 | Factor VIII polymer conjugates | BAXTER INTERNATIONAL INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-8071727-B2 | Factor VIII polymer conjugates | BAXTER INTERNATIONAL INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-8067543-B2 | Factor VIII polymer conjugates | BAXTER INTERNATIONAL INC. (US) | 2011-11-29 | — | — | US | disclosed |
| US-20110206651-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER HEALTHCARE S.A. (CH) | 2011-08-25 | — | — | US | disclosed |
| US-20110112028-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER HEALTHCARE S.A. (CH) | 2011-05-12 | — | — | US | disclosed |
| US-20110112024-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER HEALTHCARE S.A. (CH) | 2011-05-12 | — | — | US | disclosed |
| US-20110112027-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER HEALTHCARE S.A. (CH) | 2011-05-12 | — | — | US | disclosed |
| US-20110112026-A1 | FACTOR VIII POLYMER CONJUGATES | BAXTER HEALTHCARE S.A. (CH) | 2011-05-12 | — | — | US | disclosed |
| US-20110070592-A1 | DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES | BAXTER INTERNATIONAL INC. (US) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240590-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | LPO, OGA, DAO | TLR2 2159/4885LPAR1 4103/4885LPAR3 4271/4885 |
| US-20110112027-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
| US-20110112026-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
| US-20110112028-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
| US-20170157259-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
| US-20140121351-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | LPO, OGA, DAO | TLR2 2159/4885LPAR1 4103/4885LPAR3 4271/4885 |
| US-20160361430-A1 | BLOOD COAGULATION PROTEIN CONJUGATES | F13B, F12, F2 | TLR2 2499/4885LPAR1 4625/4885LPAR3 4002/4885 |
| US-20110112024-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
| US-20140024808-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
| US-20110206651-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
| US-20160120994-A1 | BLOOD COAGULATION PROTEIN CONJUGATES | F13B, F12, F2 | TLR2 2499/4885LPAR1 4625/4885LPAR3 4002/4885 |
| US-20160058842-A1 | FACTOR VIII POLYMER CONJUGATES | F8, F13B, F13A1 | TLR2 3836/4885LPAR1 4216/4885LPAR3 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.